Showing results (11-20 of 256) with videos related to
Sort By:
Pageof 26
Behavioural Pharmacology|July 30, 2016
The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's diseaseTim Karl, Brett Garner, David ChengCancers|November 12, 2013
Targeted radionuclide therapyDevrim Ersahin, Indukala Doddamane, David ChengBiometrics|May 16, 2020
Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records dataDavid Cheng, Ashwin N Ananthakrishnan, Tianxi CaiCancer Causes & Control : CCC|July 26, 2012
Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interactionTing-Yuan David Cheng, Marian L NeuhouserJournal of Neurochemistry|February 3, 2009
Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of ADMasashi Kitazawa, David Cheng, Frank M LaferlaResearch Synthesis Methods|December 20, 2022
On the double-robustness and semiparametric efficiency of matching-adjusted indirect comparisonsDavid Cheng, Eric Tchetgen Tchetgen, James SignorovitchChest|February 6, 2010
Classification of the thoroughness of mediastinal staging of lung cancerFrank Detterbeck, Jonathan Puchalski, Ami Rubinowitz, et al.Frontiers in Pharmacology|October 14, 2022
Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer's disease mouse modelRose Chesworth, David Cheng, Chloe Staub, et al.The Journal of Surgical Research|October 27, 2019
What Can We Learn About Drug Safety and Other Effects in the Era of Electronic Health Records and Big Data That We Would Not Be Able to Learn From Classic Epidemiology?Ali Zarrinpar, Ting-Yuan David Cheng, Zhiguang HuoArchives of Surgery (Chicago, Ill. : 1960)|April 22, 2005
Sestamibi scans are not all created equallySuguna Pappu, Patricia Donovan, David Cheng, et al.Pageof 26